Literature DB >> 18963765

Development of a sensitive enzyme immunoassay for plasma and salivary steroids.

A Roda1, S Girotti, S Lodi, S Preti.   

Abstract

The development of an enzyme-labelled immunoassay (EIA) of sufficient range and sensitivity for determination of plasma and salivary steroids is described. The method is based on competition in the solid phase. A fixed amount of a specific antibody is immobilized on polystyrene beads, its amount being enough to bind about 50% of a steroid-enzyme conjugate (covalently linked steroid Jhorseradish peroxidase conjugate). The initial incubation at 25 degrees of serum sample or extract with the conjugate in presence of the immobilized antibody is followed by washing and the addition of a substrate for measurement of the enzyme activity either colorimetrically by the H(2)O(2)/o-phenylenediamine method or by the luminescence reaction based on the use of H(2)O(2)/luminol. The method is precise and accurate (CV < 10% for both the intra- and inter-assay studies). The sensitivity of the colorimetric determination is similar to that of radioimmunoassay, but the luminescence method is more sensitive. Radioimmunoassay and EIA gave results in good agreement (r > 0.97). The method has also been applied to salivary steroids: the procedure is direct and only a few mu1 of saliva are required. The levels of these steroids in saliva are only about a tenth of those in serum but directly correlated with them (r > 0.85). The enzyme immunoassay proposed is sensitive and precise enough to measure these steroids accurately in saliva and plasma.

Entities:  

Year:  1984        PMID: 18963765     DOI: 10.1016/0039-9140(84)80218-0

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  5 in total

1.  Effect of intraduodenal administration of 23-methyl-UDCA diastereoisomers on bile flow in hamsters.

Authors:  C Clerici; G Dozzini; E Distrutti; G Gentili; B M Sadeghpour; B Natalini; R Pellicciari; R Rizzoli; A Roda; M A Pelli
Journal:  Dig Dis Sci       Date:  1992-05       Impact factor: 3.199

Review 2.  Isolation and determination of bile acids.

Authors:  J Kandrac; S Kevresan; J K Gu; M Mikov; J P Fawcett; K Kuhajda
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Jul-Sep       Impact factor: 2.441

3.  Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child-Pugh score and serum bile acid levels.

Authors:  D Festi; S Capodicasa; L Sandri; L Colaiocco-Ferrante; T Staniscia; E Vitacolonna; A Vestito; P Simoni; G Mazzella; P Portincasa; E Roda; A Colecchia
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

4.  Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis.

Authors:  G Mazzella; P Parini; F Bazzoli; N Villanova; D Festi; R Aldini; A Roda; A Cipolla; C Polimeni; D Tonelli
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

5.  Improved intestinal absorption of an enteric-coated sodium ursodeoxycholate formulation.

Authors:  A Roda; E Roda; E Marchi; P Simoni; C Cerrè; A Pistillo; C Polimeni
Journal:  Pharm Res       Date:  1994-05       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.